I sort of see imo where they are pushing open some new doors. I also believe it may be needed and a quicker route to partner up with another company or large biopharmaceutical thats already ahead in the research and developement of active ingredient uptake through new ingestable drug delivery technology.
I have mentioned before a company as an example that is successfully moving ahead with ingestible insulin delivery. Something similar is needed for BOT.
"Therapeutics Into Oral Formulations"
https://emisphere.com
Present collaborations. Novo Nordisk.
https://emisphere.com/partnerships/
I sort of see imo where they are pushing open some new doors. I...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.005(2.04%) |
Mkt cap ! $393.7M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 25.5¢ | 24.5¢ | $823.6K | 3.305M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 292257 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 67065 | 3 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
25.0¢ |
Change
0.005 ( 3.22 %) |
||||
| Open | High | Low | Volume | ||
| 24.5¢ | 25.5¢ | 24.5¢ | 1596484 | ||
| Last updated 15.57pm 03/05/2024 ? | |||||
| BOT (ASX) Chart |